Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Equity Average (2016 - 2025)

Mesa Laboratories' Equity Average history spans 15 years, with the latest figure at $182.6 million for Q4 2025.

  • For Q4 2025, Equity Average rose 15.31% year-over-year to $182.6 million; the TTM value through Dec 2025 reached $182.6 million, up 15.31%, while the annual FY2025 figure was $152.6 million, 43.36% down from the prior year.
  • Equity Average for Q4 2025 was $182.6 million at Mesa Laboratories, up from $175.5 million in the prior quarter.
  • Across five years, Equity Average topped out at $409.5 million in Q1 2021 and bottomed at $148.1 million in Q2 2024.
  • The 5-year median for Equity Average is $383.9 million (2022), against an average of $306.6 million.
  • The largest annual shift saw Equity Average surged 79.9% in 2021 before it tumbled 62.09% in 2024.
  • A 5-year view of Equity Average shows it stood at $397.9 million in 2021, then dropped by 4.31% to $380.7 million in 2022, then increased by 3.85% to $395.4 million in 2023, then crashed by 59.95% to $158.3 million in 2024, then grew by 15.31% to $182.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Equity Average are $182.6 million (Q4 2025), $175.5 million (Q3 2025), and $166.2 million (Q2 2025).